Accelerating the response to TB: Where we are and where we’re going – In this article published ahead of World Tuberculosis Day on March 24, Stacie Stender, an infectious disease expert with Jhpiego, calls for an accelerated global response to TB, which continues to kill over a million people each year, despite being “a disease […]
The Centers for Disease Control and Prevention is recognizing next week’s World TB Day with a report documenting continued progress against tuberculosis at in the United States, along with an troubling trend. The progress: the 3.0 cases per 100,000 people reported in 2013 (9,588 new cases) represents a more than 4 percent drop from 2012. […]
Along with three new grants targeting neglected diseases carried by “kissing bugs” “snail carrying worms” and “gender-bending bacteria,” a second round of grants from the private-public partnership of the Global Health Innovative Technology Fund will continue to target a familiar foe, with an added $5.65 million to develop a vaccine against tuberculosis, The GHIT fund […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]